United StatesÚltimas notícias

Veradermics (NYSE:MANE) reported that its VDPHL01 treatment produced an average increase of up to 23.3 hairs per square centimeter in female patients over six months.

Highway Holdings (NASDAQ:HIHO) reported fiscal 2026 revenue of $4.8 million and a shareholder-attributable net loss of $1.5 million, or $0.33 per share.

Dubai-based property tycoon Mohamed Alabbar is planning two large-scale housing and tourism developments in Syria worth at least $20 billion. He spoke to Bloomberg's Zainab Fattah.

Pediatrix Medical Group (NYSE:MD) said its second-quarter payor mix remained stable and reaffirmed its $280–$300 million 2026 Adjusted EBITDA outlook.

US President Donald Trump vowed to intensify his bombardment of Iran until Tehran stops attacking ships in the Strait of Hormuz and agrees to open the waterway. The US launched more airstrikes on Iran on Wednesday, marking the fifth straight day of attacks. Tyler Kendall reports on Bloomberg Television.

BNY (NYSE:BNY) reported second-quarter revenue of $5.7 billion alongside an adjusted earnings per share of $2.45.

Zoom CFO Michelle Chang joins Bloomberg's Vonnie Quinn and Nina Trentman on "Bloomberg Brief" to discuss what's next for the company as Zoom turns 15 years and her focus on revenue growth and shareholder value. She also talks about the use of AI in product development and the company's partnership with Anthropic.

VCI Global (NASDAQ:VCIG) reported fiscal 2025 revenue of $26.1 million, down 6.2%, and a net loss attributable to shareholders of $30.3 million.

PNC (NYSE:PNC) reported a second-quarter net income of $2.1 billion and a record total revenue of $6.9 billion.

Johnson & Johnson (NYSE:JNJ) reported second-quarter sales of $25.3 billion alongside a reported earnings per share of $2.27.

McKinsey is on the edge of a possible "golden age" as companies seek help with issues such as artificial intelligence, according to Global Managing Partner Bob Sternfels. In an interview with Francine Lacqua on July 14, Sternfels said AI and geopolitical uncertainty were the "biggest issues facing us today", but added that they also come with opportunities.

Fractyl Health (NASDAQ:GUTS) reported one-year REMAIN-1 data showing 7.8% weight regain with Revita versus 13% with sham in 45 participants.